SEC 13F Intelligence

Carlson Capital, L.P. / VRNA

Carlson Capital, L.P.’s Verona Pharma PLC Position

Does Carlson Capital, L.P. own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 33.0K shares worth $4M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2025
Shares
33.0K
% of Portfolio
+1.30%
Quarters Held
1
position exited

Position History VRNA

Reported value by quarter
Q3 ’25: $4MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202533.0K$4M+1.30%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of VRNA.